Vimal Drugs Private Limited - Company Profile

It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2009.
2009 Hyderabad, Telangana, India Active
Last Updated:
Access Report
About Vimal Drugs Private Limited

Vimal Drugs Private Limited, a active private limited company, was established on 05 May 2009 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24100TG2009PTC063551. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹7.00 Cr and a paid-up capital of ₹3.99 Cr.

It upholds a compliant status. Employing 139 professional, Its leadership includes Venkata Ravi Kumar Vasireddy (Director), Vasireddy Renuka Devi (Director), Satish Mallela (Additional Director). Past directors included Mullangi Suresh, Inti Kasi Viswanadh, Jagadam Satyanarayana. It holds ₹34.14 Cr open charges and ₹54.37 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at # 4B & 5B, Sri Teja Residency, Ravendra Society Kakatiya Hills, Kavuri Hills, Madhapur, Hyderabad, Telangana, 500081.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24100TG2009PTC063551

  • Registration Number

    063551

  • Incorporation Date

    05 May 2009

  • Authorized Capital

    ₹7.00 Cr

  • Paid-Up Capital

    ₹3.99 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 7.00 Cr
  • Paid Up Capital ₹ 3.99 Cr
  • Company Age 16 Year, 9 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 34.14 Cr
  • Satisfied Charges ₹ 54.37 Cr
  • Revenue Growth **** -33.57%
  • Profit Growth **** -92.57%
  • Ebitda **** -48.46%
  • Net Worth 5.58%
  • Total Assets **** 27.50%
Company report

Vimal Drugs Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Vimal Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Vimal Drugs Private Limited?
Current Directors
Name Designation Appointment Date Status
Venkata Ravi Kumar Vasireddy Director 21 Nov 2015 Current
Vasireddy Renuka Devi Director 17 Jan 2020 Current
Satish Mallela Additional Director 13 Apr 2021 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 06 Oct 2015 Past
Pramod Abcsdd Director 06 Oct 2015 Past
Pramod Abcsdd Director 06 Oct 2015 Past
Pramod Abcsdd Managing Director 20 Sep 2014 Past
Pramod Abcsdd Director 28 May 2012 Past
Pramod Abcsdd Director 15 Jun 2013 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Vimal Drugs.

Vimal Drugs Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 33.57% decrease. The company also saw a substantial fall in profitability, with a 92.57% decrease in profit. The company's net worth moved up by a moderate rise of 5.58%.

Vimal Drugs revenue growth over time
Vimal Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -33.57%
*******
*******
*******
*******
Revenue from Operations
*******
 -35.35%
*******
*******
*******
*******
Total Assets
*******
 27.50%
*******
*******
*******
*******
Profit or Loss
*******
 -92.57%
*******
*******
*******
*******
Net Worth
*******
 5.58%
*******
*******
*******
*******
EBITDA
*******
 -48.46%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Vimal Drugs?

In 2023, Vimal Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹341,435,423.00

Satisfied Charges

₹543,654,580.00

Charges Breakdown by Lending Institutions
  • Others : 33.78 Cr
  • Hdfc Bank Limited : 0.36 Cr
Latest Charge Details
Date Lender Amount Status
28 Feb 2025 Others ₹7.83 M Open
29 Sep 2024 Others ₹33.00 Cr Open
06 Jul 2024 Hdfc Bank Limited ₹3.01 M Open
03 Jan 2024 Hdfc Bank Limited ₹0.60 M Open
02 May 2025 Others ₹3.50 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Vimal Drugs?

Vimal Drugs has a workforce of 139 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Vimal Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vimal Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Vimal Drugs
Recent Activity within the Organization
  • Charges

    The activity A charge registered on 02 May 2025 via Charge ID 101097770 with Others was fully satisfied on 05 Aug 2025. was completed.

  • Charges

    Progress on A charge registered on 07 Feb 2024 via Charge ID 100863324 with Others was fully satisfied on 22 May 2025. was documented.

  • Charges

    Progress on A charge with Others amounted to Rs. 3.50 Cr with Charge ID 101097770 was registered on 02 May 2025. was documented.

  • Charges

    The activity A charge with Others amounted to Rs. 0.78 Cr with Charge ID 101081076 was registered on 28 Feb 2025. was completed.

  • Annual General Meeting

    Vimal Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.

  • Charges

    The activity A charge with Others amounted to Rs. 33.00 Cr with Charge ID 100981964 was registered on 29 Sep 2024. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Vimal Drugs Private Limited?

The CIN of Vimal Drugs Private Limited is U24100TG2009PTC063551.

Where is Vimal Drugs Private Limited headquartered?

Vimal Drugs Private Limited is headquartered at # 4B & 5B, Sri Teja Residency, Ravendra Society Kakatiya Hills, Kavuri Hills, Madhapur, Hyderabad, Telangana, 500081.

When was Vimal Drugs Private Limited incorporated?

Vimal Drugs Private Limited was incorporated on 05 May 2009.

Who are the current directors of Vimal Drugs Private Limited?

The current directors of Vimal Drugs Private Limited are

What is the primary industry of Vimal Drugs Private Limited?

The primary industry of Vimal Drugs Private Limited is Manufacturing.

Is Vimal Drugs Private Limited a listed company?

Vimal Drugs Private Limited is unlisted.

What is the capital structure of Vimal Drugs Private Limited?

The authorized capital of Vimal Drugs Private Limited is ₹7.00 Cr, and the paid-up capital is ₹3.99 Cr.

What is the compliance status of Vimal Drugs Private Limited?

The compliance status of Vimal Drugs Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available